The inflammatory effect on autophagy was initially reported at the periphery in various diseases including Crohn's disease [33–35], which stimulated our research to modulate the inflammatory environment of PBMCs by treating the cultures with the C16 compound, known as a specific inhibitor of PKR with anti-inflammatory properties [25, 26]. Here, EIF2AK2 is linked to Crohn disease.